Related Experiment Video
Updated: Jun 3, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Morbidity and mortality patterns in small-for-gestational age infants born preterm
Vasileios Giapros1, Aikaterini Drougia, Nikolaos Krallis
1Neonatal Intensive Care Unit, University Hospital of Ioannina, Ioannina, Greece. vgiapros@cc.uoi.gr
Insights
Premature infants who are small-for-gestational age (SGA) face higher risks of chronic lung disease (CLD) and death compared to appropriate-for-gestational age (AGA) infants. This highlights critical differences in outcomes for preterm infants based on growth metrics.
Area of Science:
- Neonatalogy
- Perinatology
- Pediatric Critical Care
Background:
- Premature neonates born small-for-gestational age (SGA) may experience greater adverse effects than those born appropriate-for-gestational age (AGA).
- Understanding the comparative morbidity and mortality in these groups is crucial for optimizing neonatal care.
Purpose of the Study:
- To compare the morbidity and mortality rates between SGA and AGA neonates born with low gestational age (GA).
- To identify specific risks associated with SGA status in preterm infants.
Main Methods:
- A 9-year study of preterm infants (GA 24-31 weeks) hospitalized in a neonatal intensive care unit (NICU).
- Assessment of SGA status association with neonatal death and major morbidities including CLD, IVH, ROP, NEC, RDS, PDA, and sepsis.
- Multiple logistic regression analysis was employed to evaluate these associations.
Main Results:
- Small-for-gestational age (SGA) neonates showed a significantly higher incidence of chronic lung disease (CLD) (57.1% vs 29.3%).
- Mortality rates were substantially higher in SGA neonates (33.3% vs 17% for AGA), particularly in subgroups (24.1% vs 6.3% for GA 28-31 weeks).
- SGA status was independently associated with increased mortality (OR 3.4) and CLD (OR 3.9) in logistic regression.
Conclusions:
- Small-for-gestational age (SGA) neonates born between 24-31 weeks GA face elevated risks for developing chronic lung disease (CLD).
- Neonatal death risk is significantly higher in SGA preterm infants compared to AGA preterm infants of similar gestational age.
Objective:
Small-for-gestational age (SGA) neonates born prematurely may be at higher risk for adverse effects during the early postnatal period than premature neonates born appropriate for gestational age (AGA).This study aims to study comparatively morbidity and mortality in SGA and AGA neonates born with low gestational age (GA).
Methods:
The study population included all preterm infants born alive with GA 24-31 weeks in Northwestern Greece during a 9-year period and hospitalized in the regional neonatal intensive care unit (NICU). The association of SGA status with neonatal death, and with chronic lung disease (CLD), intraventricular haemorrhage (IVH), retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), respiratory distress syndrome (RDS), patent ductus arteriosus (PDA), and sepsis was assessed, using multiple logistic regression analysis.
Results:
Of 210 infants without congenital anomalies born at GA 24-31 weeks, 51 were SGA and 159 were AGA. CLD was more common in SGA than in AGA neonates (57.1% vs 29.3%, p < 0.05), but no differences were found in the rates of IVH, NEC, ROP, RDS, and sepsis. The mortality rate in the SGA group was 33.3% vs 17% in the AGA group (p < 0.01), and in the subgroups 28-31 weeks 24.1% vs 6.3%, respectively, (p < 0.01). In logistic regression analysis, SGA status was strongly associated with increased mortality and CLD, independent of confounding factors [odd ratios and confidence intervals: 3.4 (CI: 1.8-10.6) p = 0.03 and 3.9 (CI: 1.7-11.5) p < 0.01, respectively.
Conclusions:
SGA neonates with GA 24-31 weeks were at increased risk of development of CLD and of neonatal death compared with AGA neonates of the same GA.
Related Concept Videos
Development of the Oral Microbiota
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

